Shares of Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) have earned an average rating of “Moderate Buy” from the six brokerages that are presently covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12-month price […]

Related Keywords

Ohio , United States , Carll Gordon , Adicet Bio , Schonfeld Strategic Advisors , Virtu Financial , Adicet Bio Company Profile , Adicet Bio Inc , Securities Exchange Commission , Nasdaq , Tower Research Capital , Wells Fargo Company , Get Free Report , Director Carl , Exchange Commission , Research Capital , Employees Retirement System , Get Free , Adicet Bio Daily , Nasdaq Acet , Facet , Medical , 00444610 , Ratings , Consensus ,